Health Sciences Acquisitions Corporation 2
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HSAQ research report →
Company
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.
- CEO
- Roderick Tze Ian Wong
- IPO
- 2020
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $149.23M
- P/E
- -15218.54
- P/S
- 4.56
- P/B
- 20266.75
- EV/EBITDA
- -3.54
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 99.46%
- Op Margin
- -167.96%
- Net Margin
- -167.63%
- ROE
- -158.09%
- ROIC
- -62.63%
Growth & Income
- Revenue
- $33.48M · 1169.22%
- Net Income
- $-52,955,000 · 13.22%
- EPS
- $-1.11 · 33.13%
- Op Income
- $-51,807,000
- FCF YoY
- 2.74%
Performance & Tape
- 52W High
- $13.80
- 52W Low
- $9.41
- 50D MA
- $10.06
- 200D MA
- $9.96
- Beta
- 0.00
- Avg Volume
- 71.38K
Get TickerSpark's AI analysis on HSAQ
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 19, 23 | Papandreou George | other | 0 |
| Sep 19, 23 | Papandreou George | other | 23,622 |
| Sep 19, 23 | Papandreou George | other | 6,278 |
| Sep 19, 23 | Papandreou George | other | 23,250 |
| Sep 19, 23 | Papandreou George | other | 30,000 |
| Sep 19, 23 | Papandreou George | other | 50,000 |
| Jul 20, 23 | Smith Geoffrey Wade | other | 16,667 |
| Jul 20, 23 | Aryeh Jason | other | 25,000 |
| Jul 20, 23 | Hochman David P | other | 300,000 |
| Jul 20, 23 | Hochman David P | other | 165,000 |
Our HSAQ Coverage
We haven't published any research on HSAQ yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HSAQ Report →